Literature DB >> 10602948

Peripheral MR angiography.

K Y Ho1, T Leiner, M W de Haan, J M van Engelshoven.   

Abstract

Atherosclerotic disease of the lower extremities is a common disorder in western society. Its debilitating nature calls for accurate diagnosis and treatment. The gold standard for diagnosing this disease by depiction of vessel morphology is X-ray angiography (either conventional or digital subtraction angiography). However, the invasive nature of this technique and the possible harmful effects of iodinated contrast agents have led to the idea that non-invasive MR angiography might be a good alternative for acquiring information about vessel morphology. Most extensively studied was time-of-flight MR angiography. Although first results with this technique were encouraging, it is now apparent that time-of-flight MR angiography is hampered by the virtue of which it exists, since blood flow not only generates vessel-to-background contrast, but is also the cause of disturbing artifacts. However, with the introduction of minimally invasive contrast-enhanced MR angiography, using gadolinium chelates to reduce the T1 of blood, image quality has improved dramatically. Moreover, using contrast-enhanced MR angiography, high-resolution three-dimensional data about the entire peripheral vascular tree can be obtained within several minutes, which might make MR angiography a true competitor of X-ray angiography as a diagnostic tool in the clinical work-up of a patient with complaints of peripheral atherosclerosis. The purpose of this article is to explain working mechanisms and usefulness of both time-of-flight and contrast-enhanced MR angiography.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10602948     DOI: 10.1007/s003300050920

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  7 in total

1.  Low-dose intra-arterial contrast-enhanced MR aortography in patients based on a theoretically derived injection protocol.

Authors:  S Potthast; A-C Schulte; G M Bongartz; R Hügli; M Aschwanden; D Bilecen
Journal:  Eur Radiol       Date:  2005-06-21       Impact factor: 5.315

2.  The impact of the dosage of intravenous gadolinium-chelates on the vascular signal intensity in MR angiography.

Authors:  Johannes T Heverhagen; Isabelle Reitz; Martina Pavlicova; Andrea L Levine; Klaus J Klose; Hans-Joachim Wagner
Journal:  Eur Radiol       Date:  2006-09-30       Impact factor: 5.315

3.  High resolution 3 Tesla contrast-enhanced MR angiography of the hands in Raynaud's disease.

Authors:  J Walcher; R Strecker; S Goldacker; J Winterer; M Langer; T A Bley
Journal:  Clin Rheumatol       Date:  2006-03-15       Impact factor: 2.980

Review 4.  Whole-Body MRA.

Authors:  Harald Kramer; Harald H Quick; Bernd Tombach; Stefan O Schoenberg; Joerg Barkhausen
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

Review 5.  Currently used non-specific extracellular MR contrast media.

Authors:  M F Bellin; M Vasile; S Morel-Precetti
Journal:  Eur Radiol       Date:  2003-06-19       Impact factor: 5.315

6.  Magnetic resonance angiographic assessment of upper extremity vessels prior to vascular access surgery: feasibility and accuracy.

Authors:  Nils R Planken; Jan H Tordoir; Lucien E Duijm; Harrie C van den Bosch; Frank M van der Sande; Jeroen P Kooman; Michiel W de Haan; Tim Leiner
Journal:  Eur Radiol       Date:  2007-07-24       Impact factor: 5.315

7.  Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent.

Authors:  B Misselwitz; H Schmitt-Willich; W Ebert; T Frenzel; H J Weinmann
Journal:  MAGMA       Date:  2001-05       Impact factor: 2.533

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.